» Articles » PMID: 11231267

Factors Affecting the Dimerization of the P66 Form of HIV-1 Reverse Transcriptase

Overview
Journal Eur J Biochem
Specialty Biochemistry
Date 2001 Mar 7
PMID 11231267
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The association and dissociation of the homodimeric p66/p66 form of HIV-1 reverse transcriptase were investigated. The effects on the dimerization process of different salt concentrations, pH and the presence of a template/primer and nucleotide substrates were monitored by measuring polymerase activity and analytical size-exclusion HPLC. At submicromolar concentrations of enzyme and physiological salt concentrations, most of the enzyme exists in the inactive monomeric form. Increasing NaCl concentration from 0.05 to 1 M decreased the equilibrium dissociation constant from 2.0 to 0.34 microM. Analysis of the kinetics of the dimerization process indicated it followed a two-step mechanism, with rapid initial association of the two subunits to form an inactive homodimer followed by a slow isomerization step rendering the active enzyme form. The presence of poly(rA)/dT(20) decreased the equilibrium dissociation constant of the homodimer about 30-fold, while the addition of 5 microM dTTP had no effect. The kinetics of the process showed that the template/primer favored dimerization by binding to the inactive homodimer and promoting its isomerization to the active form. These results were confirmed by analyzing the reverse reaction, i.e. the dissociation of the enzyme, by dilution in a low-ionic-strength buffer. The results suggest that binding of immature HIV-1 reverse transcriptase to its natural template/primer may be relevant in both the dimerization process and the selection of its natural primer.

Citing Articles

Structural Characterization of the Dimers and Selective Synthesis of the Cyclic Analogues of the Antimicrobial Peptide Cm-p5.

Morales-Vicente F, Espinosa L, Diaz-Pico E, Martell E, Gonzalez M, Ojeda G Antibiotics (Basel). 2025; 14(2).

PMID: 40001437 PMC: 11851992. DOI: 10.3390/antibiotics14020194.


Targeting the Structural Maturation Pathway of HIV-1 Reverse Transcriptase.

Kirby T, Gabel S, DeRose E, Perera L, Krahn J, Pedersen L Biomolecules. 2023; 13(11).

PMID: 38002285 PMC: 10669680. DOI: 10.3390/biom13111603.


Biophysical Characterization of p51 and p66 Monomers of HIV-1 Reverse Transcriptase with Their Inhibitors.

Seetaha S, Kamonsutthipaijit N, Yagi-Utsumi M, Seako Y, Yamaguchi T, Hannongbua S Protein J. 2023; 42(6):741-752.

PMID: 37728788 DOI: 10.1007/s10930-023-10156-y.


Probing the Interaction between HIV-1 Protease and the Homodimeric p66/p66' Reverse Transcriptase Precursor by Double Electron-Electron Resonance EPR Spectroscopy.

Schmidt T, Louis J, Clore G Chembiochem. 2020; 21(21):3051-3055.

PMID: 32558168 PMC: 7678880. DOI: 10.1002/cbic.202000263.


An asymmetry that leads to activity.

Varney K, Cook M, Weber D Proc Natl Acad Sci U S A. 2019; 116(36):17614-17615.

PMID: 31427532 PMC: 6731652. DOI: 10.1073/pnas.1912729116.